CDKN2A:

Yaelle Shaked1,2, Alyssa Swearingen1,3, Tracey N Liebman4

  • 1Ronald O. Perelman Department of Dermatology, NYU Langone Health, New York University Grossman School of Medicine, 240 E 38th St, 11th Floor, New York, NY, 10016, USA.

Dermatology and therapy
|February 8, 2025
PubMed
概括

CDKN2A突变带来重大风险,特别是在家族性黑色素瘤患者身上. 通过基因检测和定期皮肤监测进行早期检测对于管理这种遗传性癌症风险至关重要.